Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Tara Lynn Kieffer Insider Profile
4 Followers
Tara Lynn Kieffer, Chief Product Strategy Officer at Enanta Pharmaceuticals, holds 32.34K shares in Enanta Pharmaceuticals (Ticker: ENTA).
Tara Lynn Kieffer has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Tara Lynn Kieffer's holdings
Insider Roles
Chief Product Strategy Officer
Roles that Tara Lynn Kieffer holds in companies
Most Profitable Insider Trade
The most profitable trade made by Tara Lynn Kieffer
Tara Lynn Kieffer's Trading History
List of latest transactions for each holding click on a transaction to see Tara Lynn Kieffer's performance on stock
You May Also Like
Tara Lynn Kieffer insider profile FAQ
What is the percentage of profitable transactions made by Tara Lynn Kieffer?
The percentage of profitable transactions made by Tara Lynn Kieffer is ―.
What is the average return per transaction made by Tara Lynn Kieffer?
The average return per transaction made by Tara Lynn Kieffer is ―.
What stocks does Tara Lynn Kieffer hold?
Tara Lynn Kieffer holds: ENTA stocks.
What was Tara Lynn Kieffer’s latest transaction?
Tara Lynn Kieffer latest transaction was an Uninformative Sell of $89.59K.
What was Tara Lynn Kieffer's most profitable transaction?
Tara Lynn Kieffer’s most profitable transaction was an Informative Sell of ENTA stock on December 6, 2023. The return on the trade was 1.50%.
What is Tara Lynn Kieffer's role in Enanta Pharmaceuticals?
Tara Lynn Kieffer's role in Enanta Pharmaceuticals is Chief Product Strategy Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.